Selected Grants
Stimulating Access to Research in Residency (StARR) - NIAID
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2029Duke Research Training Program in Surgical Oncology
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2029Stimulating Access to Research in Residency (StARR) - NHLBI
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Heart, Lung, and Blood Institute · 2018 - 2028Decoding tumor-defining crosstalk between mesothelioma malignant cells and their associated microenvironment
ResearchPrincipal Investigator · Awarded by American Association for Thoracic Surgery · 2024 - 2026Comparative Effectiveness of Surgery vs Stereotactic Radiation Therapy for Stage I Lung Cancer
Clinical TrialPrincipal Investigator · Awarded by Washington University in St. Louis · 2022 - 2025Stimulating Access to Research in Residency (StARR) - NIAID
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2029Duke Research Training Program in Surgical Oncology
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2029Stimulating Access to Research in Residency (StARR) - NHLBI
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Heart, Lung, and Blood Institute · 2018 - 2028Decoding tumor-defining crosstalk between mesothelioma malignant cells and their associated microenvironment
ResearchPrincipal Investigator · Awarded by American Association for Thoracic Surgery · 2024 - 2026Comparative Effectiveness of Surgery vs Stereotactic Radiation Therapy for Stage I Lung Cancer
Clinical TrialPrincipal Investigator · Awarded by Washington University in St. Louis · 2022 - 2025Comparative Effectiveness of Surgery vs Stereotactic Radiation Therapy for Stage I Lung Cancer
ResearchPrincipal Investigator · Awarded by Washington University School of Medicine · 2022 - 2024A prospective, non interventional, trial evaluating the diagnostic accuracy of FBLN3 for Mesothelioma pleural effusions
ResearchPrincipal Investigator · Awarded by New York University School of Medicine · 2021 - 2023Translational Research in Surgical Oncology
Inst. Training Prgm or CMECo-Principal Investigator · Awarded by National Institutes of Health · 2002 - 2022Prospective Validation of Prognostic and Predictive Molecular tests in Mesothelioma
ResearchPrincipal Investigator · Awarded by Brigham and Women's Hospital · 2017 - 2022Military Exposure-Related Pleural Mesothelioma: An Innovative Translational Approach to Inform Novel Molecular-Targeted Treatment Development
ResearchPrincipal Investigator · Awarded by Department of Defense · 2017 - 2022A Retrospective Study of the myPlan Lung Cancer Test and Prediction of Chemotherapy Benefit in Patients with Early Stage Lung Adenocarcinoma
ResearchPrincipal Investigator · Awarded by Myriad Genetics, Inc. · 2016 - 2021Elucidating the Genome of Large Cell Lung Neuroendocrine Cancer
FellowshipPrincipal Investigator · Awarded by Thoracic Surgery Foundation for Research and Education · 2019 - 2020IPA for Tracey Taylor
ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2018 - 2020Lung Squamous Cell Carcinoma: Validation of Molecular Signatures of Prognosis
ResearchPrincipal Investigator · Awarded by University of Colorado - Denver · 2012 - 2017Clinical Oncology Research Career Development Program
ResearchMentor · Awarded by National Institutes of Health · 2009 - 2015GSK2302032A Antigen-Specific cancer Immunotherapeutic as adjuvant therapy in patients with Non-Small Cell Lung Cancer
Clinical TrialPrincipal Investigator · Awarded by GlaxoSmithKline · 2013 - 2015IPA - Joshi
ResearchPrincipal Investigator · Awarded by Veterans Administration Medical Center · 2011 - 2013IPA - Debbie Conlon
ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2012 - 2013Validating Molecular Signature Risk Models of NSCLC
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2006 - 2012Refining and Validating Genomic Signatures in Lung Cancer
ResearchCollaborator · Awarded by National Institutes of Health · 2009 - 2010Prospective Validation of Genomic Signatures of Chemosensitivity in NSCLC
ResearchCollaborator · Awarded by National Institutes of Health · 2009 - 2010Semiparametric ROC Curve Regression for Cancer Screening Studies
ResearchConsultant · Awarded by National Institutes of Health · 2007 - 2010Tissue and serum indicators of lung cancer recurrence.
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1996 - 2002Tissue And Serum Indicators Of Lung Cancer Recurrence
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1996 - 1999External Relationships
- AstraZeneca
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.